health - "develop"

New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and develop better treatments for life-threatening blood diseases.

GE Healthcare announced the commercial release of a new pre-clinical computed tomography scanner specifically designed to accelerate research in the areas of cardiac disease and drug development. The GE eXplore CT 120 scanner is an all-new design based on years of research CT scanner experience. Using x-ray source technology derived from clinical systems, the eXplore CT 120 features 100 times the output of previous GE laboratory research imaging systems.

The world will fail to reach millennium development goals unless India improves healthcare for children, the UN says.

Two studies of how brain cells process cocaine, amphetamines and antidepressants could contribute to the development of targeted medication treatments for addictions.

Commonly used cholesterol-fighting drugs called statins may protect against dementia and memory loss.'After accounting for other key predictors of dementia, we found that statin users were about half as likely to develop dementia as those who did not take them,' said study author Mary N. Haan, DrPH, with the University of Michigan School of Public health in Ann Arbor.read more

HealthDay - TUESDAY, Aug. 5 (HealthDay News) -- The drug nevirapine -- widelyused in developing countries to prevent transmission of HIV from mothersto babies -- persists in the breast milk and blood of mothers, a newStanford University study finds.

Researchers have developed a ground-breaking procedure that could avoid the need for transplant patients to spend the rest of their lives taking a cocktail of drugs to stop their system from rejecting their new organ, according to a series of papers in the August issue of Transplant International. (Source: News-Medical News Feed)

University of Utah School of Medicine researchers have developed a new tool that facilitates diagnosis of anemia related to chronic illness, as well as diseases of iron overload. The results of a study detailing the new tool are published in the August 2008 issue of the journal Cell Metabolism, a publication of Cell Press.

HealthDay - Here are some of the latest health and medical news developments,compiled by editors of HealthDay:

Dynavax Technologies Corporation (Nasdaq:DVAX) and Merck & Co., Inc. announced today top-line immunogenicity results from a Phase 3 clinical trial comparing HEPLISAV™, an investigational hepatitis B virus (HBV) vaccine, to a currently marketed HBV vaccine, Engerix-B® (1). The study achieved its primary endpoint. HEPLISAV is being jointly developed by Dynavax and Merck for use in adults and in patients with end stage renal disease. (PRWeb Aug 5, 2008) Read the full story at http://www.prweb.com/releases/heplisav/merck/prweb1182974.htm